Abstract
Dimascio, Shader, Salzman and their colleagues 1–5 conducted a series of experiments providing evidence that chlordiazepoxide produced a significantly greater increment in self-reported and behaviorally expressed hostility over a 1-week interval than did placebo in groups of college age normal male volunteers. Rickels and Downing 6 presented data indicating that a group of anxious, nonpsychotic outpatients treated with chlordiazepoxide in 4-week double-blind drug trials showed greater decrements in physician rated irritability and hostility and in self-assessed anger-hostility than did placebo treated patients. These latter findings were considered to strongly suggest that caution be exercised in generalizing results obtained in samples of asymptomatic volunteers to psychiatric patient groups. Kochansky et al. 3 have suggested that the ratings employed by Rickels and Downing to assess clinical hostility may focus upon “manifest angry affects” rather than hostility as “inner motivational or arousal level;” Kochansky et al. employed the Buss Durkee Hostility Inventory (BDHI) to assess such arousal level. The present study examines 4-week changes in hostility in anxious neurotic outpatients treated with either chlordiazepoxide (CDZ) or placebo using four scales from the BHDI (verbal hostility, indirect hostility, irritability, and resentment) in an effort to assess hostility as an inner motivational level. An Hostility Conflict Scale 7 intended to assess the level of conflict or guilt about the expression of hostility was also administered. It was felt that the potential for CDZ-facilitated hostility increase might be greater among patients with greater amounts of conflict associated with hostility expression since the drug might be expected to allay anxiety associated with such conflict.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.